Skip to content

A clinical study of rice protein peptides in improving protein malnutrition in cancer patients

A clinical study of rice protein peptides in improving protein malnutrition in cancer patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047263
Enrollment
Unknown
Registered
2021-06-11
Start date
2021-06-20
Completion date
Unknown
Last updated
2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor, malnutrition

Interventions

Experimental group:Use rice protein peptide
Control group:Use whey protein powder

Sponsors

Department of Clinical Nutrition, Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 90 years, no gender limit; 2. Patients diagnosed with digestive system tumors; 3. Patients with 28g/L=3 points; 5. Able to understand the purpose of the trial, voluntarily participate in and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to the ingredients contained in research supplies; 2. People with severe systemic diseases (such as cardiovascular, respiratory, digestive, neurological, endocrine, genitourinary diseases, etc.) and unstable conditions, such as brain and bone metastases, large amounts of pleural fluid, etc.; 3. Those who suffer from mental illness, including severe hysteria, and are involuntary; 4. Liver function damage: ALT or AST is greater than 3 times the upper limit of normal; 5. Abnormal renal function: serum creatinine (Cr) is greater than 1.5 times the upper limit of normal; 6. History of drug abuse or alcohol abuse; 7. Participate in other drug clinical trials within 30 days before this trial; 8. The investigator judged that the patient had poor compliance and could not complete the study as required; 9. Albumin was injected during the test period.

Design outcomes

Primary

MeasureTime frame
albumin;Total protein;Prealbumin;Retinol binding protein;

Secondary

MeasureTime frame
Lean body mass;Transferrin;Immunoglobulin A;Immunoglobulin M;Immunoglobulin G;Interleukin-6;High-sensitivity C-reactive protein;Tumor necrosis factor;

Countries

China

Contacts

Public ContactZheng Xuan

Department of Clinical Nutrition, Shanghai Changhai Hospital

15921811369@163.com+86 15921811369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026